Paul Bouter
Impact in
- Nephrology top 2%
- Chronic Kidney Disease and Diabetes
- Renal Diseases and Glomerulopathies
-
- Renin-Angiotensin System Studies
- Blood Pressure and Hypertension Studies
Papers in
-
- Diabetes Treatment and Management 3
- Diabetes Management and Research 2
- Diabetes, Cardiovascular Risks, and Lipoproteins 1
-
- Urinary Tract Infections Management 2
- Cytomegalovirus and herpesvirus research 1
- Adipokines, Inflammation, and Metabolic Diseases 1
- Co-authors
- Stephen Charles Bain (1 shared paper)Anthony H Barnett (1 shared paper)Jak Jervell (1 shared paper)Bengt E. Karlberg (1 shared paper)Sten Madsbad (1 shared paper)Jukka T. Mustonen (1 shared paper)Frank L.J. Visseren (2 shared papers)Rob J. A. Diepersloot (1 shared paper)
- Journals
- New England Journal of Medicine (1 paper)Advances in experimental medicine and biology (1 paper)Diabetologia (1 paper)Clinical Drug Investigation (1 paper)UCL Discovery (University College London) (1 paper)
- Partner nations
- NetherlandsFinlandSweden
In The Last Decade
Paul Bouter
8 papers receiving 706 citations
Paul Bouter's Hit Papers
Peers
Comparison fields: 5 of 62
- Nephrology 370
- Cardiology and Cardiovascular Medicine 327
- Endocrinology, Diabetes and Metabolism 71
- Endocrinology 5
- Transplantation 4
Countries citing papers authored by Paul Bouter
This map shows the geographic impact of Paul Bouter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul Bouter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul Bouter more than expected).
Fields of papers citing papers by Paul Bouter
This network shows the impact of papers produced by Paul Bouter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul Bouter. The network helps show where Paul Bouter may publish in the future.
Co-authors
The 20 scholars most cited alongside Paul Bouter, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Angiotensin-Receptor Blockade versus Converting–Enzyme Inhibition in Type 2 Diabetes and Nephropathy Hit paper breakdown → | 2004 | 686 |
| 2 | 2004 | 48 | |
| 3 | 2002 | 24 | |
| 4 | 2004 | 22 | |
| 5 | GENES AND PROTEINS UNDERLYING MICROBIAL URINARY TRACT VIRULENCE | 2000 | 6 |
| 6 | 2001 | 5 | |
| 7 | 40th EASD Annual Meeting of the European Association for the Study of Diabetes : Munich, Germany, 5-9 September 2004. | 2004 | 3 |
| 8 | 2012 | 1 | |
| 9 | 2022 | 0 |
About Paul Bouter
Paul Bouter is a scholar working on Endocrinology, Diabetes and Metabolism, Epidemiology, Endocrinology, Microbiology and Nephrology, having authored 9 papers that have together received 795 indexed citations. Recurring topics across this work include Diabetes Treatment and Management (3 papers), Urinary Tract Infections Management (2 papers), Diabetes Management and Research (2 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (1 paper), Escherichia coli research studies (1 paper), Cytomegalovirus and herpesvirus research (1 paper), Adipokines, Inflammation, and Metabolic Diseases (1 paper) and Atherosclerosis and Cardiovascular Diseases (1 paper). The work is most often cited by research in Nephrology (370 citations), Cardiology and Cardiovascular Medicine (327 citations), Endocrinology, Diabetes and Metabolism (71 citations), Endocrinology (5 citations) and Transplantation (4 citations). Paul Bouter has collaborated with scholars based in Netherlands, Finland and Sweden. Frequent co-authors include Stephen Charles Bain, Anthony H Barnett, Jak Jervell, Bengt E. Karlberg, Sten Madsbad, Jukka T. Mustonen, Frank L.J. Visseren, Rob J. A. Diepersloot, John J. M. Bouwman and Andy I. M. Hoepelman. Their work appears in journals such as New England Journal of Medicine, Advances in experimental medicine and biology, Diabetologia, Clinical Drug Investigation and UCL Discovery (University College London).
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.